Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers

被引:0
|
作者
Kolano, Pawel [1 ]
Bednarski, Igor A. [2 ]
Kraska-Gacka, Marzena [3 ]
Narbutt, Joanna [2 ]
Lesiak, Aleksandra [2 ]
机构
[1] Tomaszow Hlth Ctr, Dept Gen & Oncol Surg, Tomaszow Mazowiecki, Poland
[2] Med Univ Lodz, Dermatol Pediat Dermatol & Oncol Clin, 1-5 Kniaziewicza St, PL-91347 Lodz, Poland
[3] Med Univ Lodz, Dept Dermatol & Venereol, Lodz, Poland
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2021年 / 38卷 / 02期
关键词
venous leg ulcers; cathepsin K; ENDOTHELIAL GROWTH-FACTOR; POOR-PROGNOSIS; DISEASE; VEGF;
D O I
10.5114/ada.2021.106201
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Leg ulcers are a frequently observed medical problem affecting 3-5% of the general population over 65 years of age. The most common factor responsible for the development of leg ulcers is chronic venous insufficiency (CVI). It is believed that during the formation of an ulcer there are two processes occurring simultaneously, extracellular matrix (ECM) degradation and angiogenesis in which several proteins including matrix metalloproteinases, angiogenic and regulatory factors are engaged. Aim: To determine the serum concentration of matrix metalloproteinase-1 (MMP-1), -9 (MMP-9), tissue inhibitors of metalloproteinases-1 (TIMP-1), angiogenin and vascular endothelial growth factor (VEGF) in patients suffering from venous leg ulcers and in the healthy control group. Material and methods: The study group consisted of 71 Caucasians (39 patients, 32 controls). To evaluate the serum concentration of MMP-1, MMP-9, TIMP-1, VEGF and angiogenin, the ELISA technique was used. Results: Mean MMP-1 and MMP-9 concentrations in the study group were 14.16 +/- 2.98 and 12.45 +/- 3.85 ng/ml, respectively, and in controls 6.08 +/- 2.51 ng/ml and 6.77 +/- 2.41 ng/ml, respectively and both differences were statistically significant (p < 0.001). There was no significant difference between the study and the control group in TIMP-1 concentration. Mean VEGF and ANG concentrations in the study group were 589.3 +/- 346.2 pg/ml and 1802.0 +/- 415.7 pg/ml, respectively, and in controls 220.3 +/- 110.4 pg/ml and 1229.0 +/- 337.7 pg/ml, respectively and both differences were statistically significant (p < 0.001). Conclusions: Lack of significant differences in the concentration of TIMP-1 between the control and the study group confirms that proteolysis is a hallmark of CVI, but increased concentration of VEGF and angiogenin in the study group compared to the control group shows that angiogenesis occurs simultaneously with ECM remodelling.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 50 条
  • [31] Venous leg ulcers: a guide for patients and caregivers (video).
    Husband, L
    JOURNAL OF ADVANCED NURSING, 2000, 32 (05) : 1307 - 1307
  • [32] RETESTING OF PATIENTS WITH LOWER LEG DERMATITIS AND VENOUS ULCERS
    LINDEMAYR, H
    DROBIL, M
    ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1983, 58 (11): : 807 - &
  • [33] Contact allergy in patients with chronic venous leg ulcers
    Lossius, Astrid H.
    Lorentzen, Merete
    Austad, Joar
    Bergersen, Tone K.
    CONTACT DERMATITIS, 2021, 84 (06) : 470 - 472
  • [34] Roles of pro-angiogenic and anti-angiogenic factors as well as matrix metalloproteinases in healing of NSAID-induced small intestinal ulcers in rats
    Gyenge, Melinda
    Amagase, Kikuko
    Kunimi, Shino
    Matsuoka, Rie
    Takeuchi, Koji
    LIFE SCIENCES, 2013, 93 (12-14) : 441 - 447
  • [35] Risk factors for healing and recurrence of chronic venous leg ulcers
    Barwell, JR
    Ghauri, ASK
    Taylor, M
    Deacon, J
    Wakely, C
    Poskitt, KR
    Whyman, MR
    PHLEBOLOGY, 2000, 15 (02) : 49 - 52
  • [36] Protease-modulating matrix treatments for healing venous leg ulcers
    Westby, Maggie J.
    Norman, Gill
    Dumville, Jo C.
    Stubbs, Nikki
    Cullum, Nicky
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (12):
  • [37] The use of a collagen matrix in hard-to-heal venous leg ulcers
    Romanelli, M.
    Mulder, G.
    Paggi, B.
    Macchia, M.
    Panduri, S.
    Dini, V.
    JOURNAL OF WOUND CARE, 2015, 24 (11) : 543 - 547
  • [38] Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer
    Komorowski, J
    Pasieka, Z
    Jankiewicz-Wika, J
    Stepien, H
    THYROID, 2002, 12 (08) : 655 - 662
  • [39] FACTOR-XIII-ACTIVITY IN THE BLOOD OF PATIENTS WITH VENOUS LEG ULCERS AND WITH LEG ULCERS OF VARIOUS ETIOLOGY
    VANSCHEIDT, W
    HASLER, K
    WOKALEK, H
    NIEDNER, R
    SCHOPF, E
    PHLEBOLOGY 89: PROCEEDINGS OF THE 10TH WORLD CONGRESS OF THE UNION-INTERNATIONALE-DE-PHLEBOLOGIE, 1989, : 131 - 133
  • [40] Ultrasound patterns of venous disease in patients with venous leg ulcers and morbid obesity
    Moss, Jana-Lee
    Pugliese, Matthew
    Richards, Toby
    PHLEBOLOGY, 2022, 37 (10) : 732 - 738